Butyrate is a potent inhibitor of urokinase secretion by normal colonic epithelium in vitro

Gastroenterology

Volumn 107, Issue 2, 1994, Pages 410-419

  Gibson, Peter R ^a   Rosella, Ourania ^a   Rosella, Gennaro ^a   Young, Graeme P ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; BUTYRIC ACID; DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROPIONIC ACID; PROTEIN; RNA; UROKINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON CANCER; COLON MUCOSA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYPT CELL; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0027979012     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(94)90166-X     Document Type: Article

References (68)

1. Surface receptors for urokinase plasminogen activator
2. Human plasma fibronectin as a substrate for human urokinase
3. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants
4. Function of receptor-bound urokinase
5. Plasminogen activators and their inhibitors: regulators of extracellular proteolysis and cell function
6. Plasminogen activator inhibitors
7. Protein C inhibitor: structure and function
8. Protease nexins and cellular regulation
9. Cell associated urokinase activity and colonic epithelial cells in health and disease
10. Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin
11. Regulation of intestinal epithelial cell growth by transforming growth factor type β
12. Effects of growth factors on an intestinal epithelial cell line: transforming growth factors α and β in rat intestinal epithelial cells
13. Effects of growth factors on an intestinal epithelial cell line transforming growth factor β inhibits proliferation and stimulates differentiation
14. Transforming growth factor β regulation of migration in wounded rat intestinal epithelial monolayers
15. Cadherins: a molecular family important in selective cell-cell adhesion
16. Distinct localizations of urokinase-type plasminogen activator and its type I inhibitor under cultured human fibroblasts and sarcoma cells
17. Local function of urokinase receptor at the adhesion contact sites of a metastatic tumour cell
18. Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells
19. Plasminogen activators in epithelial biology
20. Expression of urokinase-type plasminogen activator in the mucosal lesions of inflammatory bowel disease
21. Plasminogen activators in the intestine of patients with inflammatory bowel disease
22. Chromium 51-ethylenediaminetetraacetate test: a useful test in the assessment of inflammatory bowel disease
23. Crypt cell production rate in ulcerative proctocolitis: differential increments in remission and relapse
24. Short-chain fatty acids in the human colon
25. Pathogenic factors in inflammatory bowel disease. I. Ulcerative colitis
26. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man
27. Contrasting effects of butyrate on expression of phenotypic markers of differentiation in neoplastic and nonneoplastic colonic epithelial cells in vitro
28. Effect of butyric acid on lung-colonizing ability of cloned low-metastatic Lewis lung carcinoma cells
29. Effect of butyrate on the expression of the human preprourokinase gene introduced into Chinese hamster ovary cells
30. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate
31. Alterations in plasminogen activator and inhibitor activity during the differentiation of a human neuroblastoma cell line, SMS-KAN
32. Isolation of colonic crypts that maintain structural and metabolic viability in vitro
33. Serum-free medium increases expression of markers of differentiation in human colonic crypt cells
34. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding
35. Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer
36. A sensitive coupled assay for plasminogen activator using a thiol ester substrate for plasmin
37. Urokinase-type plasminogen activator in colorectal carcinomas and adenomatous polyps quantitative expression of active and proenzyme
38. Measurement of plasminogen activator inhibitor (PAI-1) in biological fluids, with a murine monoclonal antibody based enzyme-linked immuno-absorbent assay
39. Glycoprotein synthesis and secretion by mucosal biopsies of rabbit colon and human rectum
40. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
41. A labile repressor acts through the NFkB-like binding sites of the human urokinase gene
42. Cloning and sequence of a cDNA coding for the human β-migrating endothelial-cell-type plasminogen activator inhibitor
43. A new colon carcinoma cell line (LIM1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro
44. A comparison of the effect of several factors on the plasminogen activator activity of cloned lines from an ethylnitrosourea-induced glioma and from normal tissue
45. Activation and proliferation signals in murine macrophages. Biochemical signals controlling the regulation of macrophage urokinase-type plasminogen activator activity by colony-stimulating factors and other agents
46. Fibrin degradation by pulmonary alveolar epithelial cells
47. Molecular and cellular effects of sodium butyrate
48. Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts
49. Effects of sodium butyrate, a new pharmacological agent, on cells in culture
50. Antigens on the basement membrane and the peritumoral stroma in human colonic adenocarcinoma: an immunofluorescent study
51. Localization of plasminogen activators in human colon cancer by immunoperoxidase staining
52. Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans
53. Immunolocalization of urokinasetype plasminogen activator in adenomas and carcinomas of the colorectum
54. Plasminogen activator inhibitor 1 in human carcinoma tissues
55. Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomas
56. Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells
57. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas
58. Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization
59. Treatment of diversion colitis with short-chain fatty acid irrigation
60. Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report
61. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis
62. Neoplasia and hyperplasia of large bowel: focal lesions in an abnormal epithelium
63. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer
64. Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel
65. Immunohistochemical detection of abnormal cell proliferation in colonic mucosa of subjects with polyps
66. Background mucosal changes in colorectal carcinomas
67. Colon epithelium. IV. Human colon carcinogenesis. Changes in human colon mucosa adjacent to and remote from carcinomas of the colon